S., Grzekowiak, M., Reis, S
They are not approved for diagnostic, therapeutic, or recreational use
For example, after GLP-1 binding the transmembrane helices 1 (TM1) rotates clockwise when looking down the membrane helices from the extracellular face (see TM1 marked in Figure 6) and a kink is introduced in the transmembrane helix 6 (TM6), as is typical for all class B1 GPCRs
This peptide is prohibited by the World Anti-Doping Agency (WADA), and athletes subject to drug testing can face sanctions for using it
Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data